Search

Your search keyword '"Travis, Simon P. L."' showing total 21 results
Start Over Author "Travis, Simon P. L." Journal gut
21 results on '"Travis, Simon P. L."'

1. Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response

Author

Adams, Alex, primary, Gupta, Vipin, additional, Mohsen, Waled, additional, Chapman, Thomas P, additional, Subhaharan, Deloshaan, additional, Kakkadasam Ramaswamy, Pradeep, additional, Kumar, Sudheer, additional, Kedia, Saurabh, additional, McGregor, Colleen GC, additional, Ambrose, Tim, additional, George, Bruce D, additional, Palmer, Rebecca, additional, Brain, Oliver, additional, Walsh, Alissa, additional, Ahuja, Vineet, additional, Travis, Simon P L, additional, and Satsangi, Jack, additional

Published
2022
Full Text
View/download PDF

3. Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response.

Author

Adams, Alex, Gupta, Vipin, Mohsen, Waled, Chapman, Thomas P., Subhaharan, Deloshaan, Ramaswamy, Pradeep Kakkadasam, Kumar, Sudheer, Kedia, Saurabh, McGregor, Colleen G. C., Ambrose, Tim, George, Bruce D., Palmer, Rebecca, Brain, Oliver, Walsh, Alissa, Ahuja, Vineet, Travis, Simon P. L., and Satsangi, Jack

Subjects
LOW-molecular-weight heparin, INFLAMMATORY bowel diseases, STEROIDS
Published
2023
Full Text
View/download PDF

5. Biosimilars in IBD: hope or expectation?

Author

Gecse, Krisztina B, Khanna, Reena, van den Brink, Gijs R, Ponsioen, Cyriel Y, Löwenberg, Mark, Jairath, Vipul, Travis, Simon P L, Sandborn, William J, Feagan, Brian G, and DʼHaens, Geert R A M

Published
2013
Full Text
View/download PDF

7. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohnʼs disease: unexpected results of a randomised, double-blind placebo-controlled trial

Author

Hueber, Wolfgang, Sands, Bruce E, Lewitzky, Steve, Vandemeulebroecke, Marc, Reinisch, Walter, Higgins, Peter D R, Wehkamp, Jan, Feagan, Brian G, Yao, Michael D, Karczewski, Marek, Karczewski, Jacek, Pezous, Nicole, Bek, Stephan, Bruin, Gerard, Mellgard, Bjoern, Berger, Claudia, Londei, Marco, Bertolino, Arthur P, Tougas, Gervais, and Travis, Simon P L

Published
2012
Full Text
View/download PDF

10. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Author

Travis, Simon P L, Schnell, Dan, Krzeski, Piotr, Abreu, Maria T, Altman, Douglas G, Colombel, Jean-Frédéric, Feagan, Brian G, Hanauer, Stephen B, Lémann, Marc, Lichtenstein, Gary R, Marteau, Phillippe R, Reinisch, Walter, Sands, Bruce E, Yacyshyn, Bruce R, Bernhardt, Christian A, Mary, Jean-Yves, and Sandborn, William J

Published
2012
Full Text
View/download PDF

12. Establishment of a validated central reading system for ileocolonoscopy in an academic setting.

Author

Raine, Tim, Pavey, Holly, Qian, Wendi, Moran, Gordon W., Subramanian, Sreedhar, Swaby, Lizzie, Travis, Simon P. L., Din, Shahida, Irving, Peter M., Lindsay, James O., Parkes, Miles, and Kennedy, Nicholas A.

Subjects
INTESTINAL diseases, INFLAMMATORY bowel diseases, CROHN'S disease, MYCOBACTERIUM avium paratuberculosis, STEM cell transplantation, CERTOLIZUMAB pegol, BOWEL preparation (Procedure)
Published
2022
Full Text
View/download PDF

14. Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial

Author

Panaccione, Remo, primary, Colombel, Jean-Frederic, additional, Travis, Simon P L, additional, Bossuyt, Peter, additional, Baert, Filip, additional, Vaňásek, Tomáš, additional, Danalıoğlu, Ahmet, additional, Novacek, Gottfried, additional, Armuzzi, Alessandro, additional, Reinisch, Walter, additional, Johnson, Scott, additional, Buessing, Marric, additional, Neimark, Ezequiel, additional, Petersson, Joel, additional, Lee, Wan-Ju, additional, and D’Haens, Geert R, additional

Published
2019
Full Text
View/download PDF

15. Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial.

Author

Panaccione, Remo, Colombel, Jean-Frederic, Travis, Simon P. L., Bossuyt, Peter, Baert, Filip, Vaňásek, Tomáš, Danalıoğlu, Ahmet, Novacek, Gottfried, Armuzzi, Alessandro, Reinisch, Walter, Johnson, Scott, Buessing, Marric, Neimark, Ezequiel, Petersson, Joel, Lee, Wan-Ju, and D'Haens, Geert R.

Subjects
CROHN'S disease, THERAPEUTICS, INFLAMMATORY bowel diseases, MEDICAL economics, ECONOMIC models
Published
2020
Full Text
View/download PDF

16. Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.

Author

McGregor, Colleen G. C., Adams, Alex, Sadler, Ross, Arancibia-Cárcamo, Carolina V., Palmer, Rebecca, Ambrose, Tim, Brain, Oliver, Walsh, Alissa, Klenerman, Paul, Travis, Simon P. L., Croft, Nicholas M., Lindsay, James O., and Satsangi, Jack

Subjects
COVID-19 pandemic, SEROPREVALENCE, CHRONIC pancreatitis, MEDICAL personnel, SARS-CoV-2, VEDOLIZUMAB, GASTROENTEROLOGISTS
Published
2021
Full Text
View/download PDF

17. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up

Author

Bryant, Robert V, primary, Burger, Daniel C, additional, Delo, Joseph, additional, Walsh, Alissa J, additional, Thomas, Sally, additional, von Herbay, Axel, additional, Buchel, Otto C, additional, White, Lydia, additional, Brain, Oliver, additional, Keshav, Satish, additional, Warren, Bryan F, additional, and Travis, Simon P L, additional

Published
2015
Full Text
View/download PDF

18. Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

Author

Travis, Simon P L, primary, Danese, Silvio, additional, Kupcinskas, Limas, additional, Alexeeva, Olga, additional, D'Haens, Geert, additional, Gibson, Peter R, additional, Moro, Luigi, additional, Jones, Richard, additional, Ballard, E David, additional, Masure, Johan, additional, Rossini, Matteo, additional, and Sandborn, William J, additional

Published
2013
Full Text
View/download PDF

19. A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts

Author

Leedham, Simon J, primary, Rodenas-Cuadrado, Pedro, additional, Howarth, Kimberley, additional, Lewis, Annabelle, additional, Mallappa, Sreelakshmi, additional, Segditsas, Stefania, additional, Davis, Hayley, additional, Jeffery, Rosemary, additional, Rodriguez-Justo, Manuel, additional, Keshav, Satish, additional, Travis, Simon P L, additional, Graham, Trevor A, additional, East, James, additional, Clark, Susan, additional, and Tomlinson, Ian P M, additional

Published
2012
Full Text
View/download PDF

20. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Author

Travis, Simon P L, primary, Schnell, Dan, additional, Krzeski, Piotr, additional, Abreu, Maria T, additional, Altman, Douglas G, additional, Colombel, Jean-Frédéric, additional, Feagan, Brian G, additional, Hanauer, Stephen B, additional, Lémann, Marc, additional, Lichtenstein, Gary R, additional, Marteau, Phillippe R, additional, Reinisch, Walter, additional, Sands, Bruce E, additional, Yacyshyn, Bruce R, additional, Bernhardt, Christian A, additional, Mary, Jean-Yves, additional, and Sandborn, William J, additional

Published
2011
Full Text
View/download PDF

21. Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit.

Author

Hearnshaw, Sarah A., Logan, Richard F. A., Lowe, Derek, Travis, Simon P. L., Murphy, Mike F., and Palmer, Kelvin R.

Subjects
ENDOSCOPY, GASTROINTESTINAL hemorrhage, COMORBIDITY, HEMODYNAMICS, HEALTH outcome assessment, HOSPITALS
Abstract

OBJECTIVES: To examine the use of endoscopy in the UK for acute upper gastrointestinal bleeding (AUGIB) and compare with published standards. To assess the organisation of endoscopy services for AUGIB in the UK. To examine the relationship between outcomes and out of hours (OOH) service provision. DESIGN: Multi-centre cross sectional clinical audit. SETTING: All UK hospitals accepting admissions with AUGIB. PATIENTS: All adults (≥16 yrs) presenting with AUGIB between 1st May and 30th June 2007. DATA COLLECTION: A custom designed web-based reporting tool was used to collect data on patient characteristics, comorbidity and haemodynamic status at presentation to calculate the Rockall score, use and timing of endoscopy, treatment including endoscopic, rebleeding and in-hospital mortality. A mailed questionnaire was used to collect data on facilities and service organisation. RESULTS: Data on 6750 patients (median age 68 years) were analysed from 208 hospitals. 74% underwent inpatient endoscopy; of these 50% took place within 24 h of presentation, 82% during normal working hours and 3% between midnight and 8 am. Of patients deemed high-risk (pre-endoscopy Rockall score ≥5) only 55% were endoscoped within 24 h and 14% waited ≥72 h for endoscopy. Lesions with a high risk of rebleeding were present in 28% of patients of whom 74% received endoscopic therapy. Further bleeding was evident in 13% and mortality in those endoscoped was 7.4% (95% CI 6.7% to 8.1%). In 52% of hospitals a consultant led out of hours (OOH) endoscopy rota existed; in these hospitals 20% of first endoscopies were performed OOH compared with 13% in those with no OOH rota and endoscopic therapy was more likely to be administered (25% vs 21% in hospitals with no OOH rota). The risk adjusted mortality ratio was higher (1.21, p=0.10, (95%CI 0.96 to 1.51)) in hospitals without such rotas. CONCLUSIONS: This audit has found continuing delays in performing endoscopy after AUGIB and underutilisation of standard endoscopic therapy particularly for variceal bleeding. In hospitals with a formal OOH endoscopy rota patients received earlier endoscopy, were more likely to receive endoscopic therapy and may have a lower mortality. [ABSTRACT FROM AUTHOR]

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results